UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Pharmacokinetic, pharmacodynamic, and tolerability profiles of the dipeptidyl peptidase-4 inhibitor alogliptin: A randomized, double-blind, placebo-controlled, multiple-dose study in adult patients with type 2 diabetes

Clinical therapeutics, 2008-03, Vol.30 (3), p.499-512

2008

Volltextzugriff (PDF)

Pharmacokinetics, pharmacodynamics, and tolerability of single increasing doses of the dipeptidyl peptidase-4 inhibitor alogliptin in healthy male subjects

Clinical therapeutics, 2008-03, Vol.30 (3), p.513-527

2008

Volltextzugriff (PDF)

Alogliptin Use in Elderly People: A Pooled Analysis from Phase 2 and 3 Studies

Journal of the American Geriatrics Society (JAGS), 2009-11, Vol.57 (11), p.2011-2019

2009

Volltextzugriff (PDF)

Coadministration of Pioglitazone or Glyburide and Alogliptin: Pharmacokinetic Drug Interaction Assessment in Healthy Participants

Journal of clinical pharmacology, 2009-10, Vol.49 (10), p.1210-1219

2009

Volltextzugriff (PDF)

Effect of Low- and High-Fat Meals on Tacrolimus Absorption following 5 mg Single Oral Doses to Healthy Human Subjects

Journal of clinical pharmacology, 2001-02, Vol.41 (2), p.176-182

2001

Volltextzugriff (PDF)

Effect of Time of Meal Consumption on Bioavailability of a Single Oral 5 mg Tacrolimus Dose

Journal of clinical pharmacology, 2001-03, Vol.41 (3), p.289-297

2001

Volltextzugriff (PDF)

Efficacy and Safety of the Dipeptidyl Peptidase-4 Inhibitor Alogliptin in Patients With Type 2 Diabetes and Inadequate Glycemic Control

Diabetes care, 2008-12, Vol.31 (12), p.2315-2317

2008

Volltextzugriff (PDF)

Efficacy and Safety of the Dipeptidyl Peptidase-4 Inhibitor Alogliptin in Patients With Type 2 Diabetes and Inadequate Glycemic Control : A randomized, double-blind, placebo-controlled study

Diabetes care, 2008-12, Vol.31 (12), p.2315-2317

2008

Volltextzugriff (PDF)

Comparative Tacrolimus Pharmacokinetics: Normal versus Mildly Hepatically Impaired Subjects

Journal of clinical pharmacology, 2001-06, Vol.41 (6), p.628-635

2001

Volltextzugriff (PDF)

Initial Combination Therapy With Alogliptin and Pioglitazone in Drug-Naïve Patients With Type 2 Diabetes

Diabetes care, 2010-11, Vol.33 (11), p.2406-2408

2010

Volltextzugriff (PDF)

Efficacy and safety of the dipeptidyl peptidase-4 inhibitor alogliptin added to pioglitazone in patients with type 2 diabetes: a randomized, double-blind, placebo-controlled study

Current medical research and opinion, 2009-10, Vol.25 (10), p.2361-2371

2009

Volltextzugriff (PDF)

Pharmacokinetics of tacrolimus in liver transplant patients

Clinical pharmacology and therapeutics, 1995-03, Vol.57 (3), p.281-290

1995

Volltextzugriff (PDF)

Coadministration of Tacrolimus and Mycophenolate Mofetil in Stable Kidney Transplant Patients: Pharmacokinetics and Tolerability

Journal of clinical pharmacology, 2000-05, Vol.40 (5), p.527-532

2000

Volltextzugriff (PDF)

Bioequivalence of 1 and 5 mg Tacrolimus Capsules Using a Replicate Study Design

Journal of clinical pharmacology, 1999-10, Vol.39 (10), p.1032-1037

1999

Volltextzugriff (PDF)

Dose linearity after oral administration of tacrolimus 1-mg capsules at doses of 3, 7, and 10 mg

Clinical therapeutics, 1999-12, Vol.21 (12), p.2058-2064

1999

Volltextzugriff (PDF)

Tacrolimus oral bioavailability doubles with coadministration of ketoconazole

Clinical pharmacology and therapeutics, 1997-07, Vol.62 (1), p.41-49

1997

Volltextzugriff (PDF)

Pharmacokinetic, Pharmacodynamic, and olerability Profiles of the Dipeptidyl Peptidase-4 Inhibitor Alogliptin : A Randomized, Double-Blind, Placebo-Controlled, Multiple-Dose Study in Adult Patients with Type 2 Diabetes

Clinical therapeutics, 2008, Vol.30 (3), p.499-512

2008

Volltextzugriff (PDF)

Efficacy and safety of tacrolimus in patients with rheumatoid arthritis: A double‐blind trial

Arthritis and rheumatism, 2003-12, Vol.48 (12), p.3328-3337

2003

Volltextzugriff (PDF)

Tacrolimus in rheumatoid arthritis patients receiving concomitant methotrexate: A six-month, open-label study

Arthritis and rheumatism, 2003-10, Vol.48 (10), p.2763-2768

2003

Volltextzugriff (PDF)

Effect of Low- and High-Fat Meals on Tacrolimus Absorption following 5 mg Single Oral Doses to Healthy Human Subjects

Journal of clinical pharmacology, 2001-02, Vol.41 (2), p.176-182

2001

Volltextzugriff (PDF)

Cytomegalovirus infection and posttransplant lymphoproliferative disease in renal transplant recipients: results of the U.S. multicenter FK506 Kidney Transplant Study Group

Transplantation, 1999-10, Vol.68 (8), p.1203-1205

Pirsch, J D

1999

Volltextzugriff (PDF)

Bioequivalence of 1 and 5 mg Tacrolimus Capsules Using a Replicate Study Design

Journal of clinical pharmacology, 1999-10, Vol.39 (10), p.1032-1037

1999

Volltextzugriff (PDF)

Plasma concentrations and disposition of clonidine following a constant 14-day epidural infusion in cancer patients

Clinical therapeutics, 1997-09, Vol.19 (5), p.1024-1030

1997

Volltextzugriff (PDF)

Coadministration of Tacrolimus and Mycophenolate Mofetil in Stable Kidney Transplant Patients: Pharmacokinetics and Tolerability

Journal of clinical pharmacology, 2000-05, Vol.40 (5), p.527-532

2000

Volltextzugriff (PDF)

BROMOCRIPTINE LOWERS INTRAOCULAR PRESSURE WITHOUT AFFECTING BLOOD PRESSURE

The Lancet (British edition), 1983-06, Vol.321 (8336), p.1250-1251

1983

Volltextzugriff (PDF)

1 – 25 von 31

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(25)
Mit Volltextzugriff
(20)

Publikationsform

Artikel
(31)

Sprache

Englisch
(31)
Japanisch
(1)

Erscheinungsjahr

n.n

Menü

Weitere Dienste

Einstellungen

Pharmacokinetic, pharmacodynamic, and tolerability profiles of the dipeptidyl peptidase-4 inhibitor alogliptin: A randomized, double-blind, placebo-controlled, multiple-dose study in adult patients with type 2 diabetes

Pharmacokinetics, pharmacodynamics, and tolerability of single increasing doses of the dipeptidyl peptidase-4 inhibitor alogliptin in healthy male subjects

Alogliptin Use in Elderly People: A Pooled Analysis from Phase 2 and 3 Studies

Coadministration of Pioglitazone or Glyburide and Alogliptin: Pharmacokinetic Drug Interaction Assessment in Healthy Participants

Effect of Low- and High-Fat Meals on Tacrolimus Absorption following 5 mg Single Oral Doses to Healthy Human Subjects

Effect of Time of Meal Consumption on Bioavailability of a Single Oral 5 mg Tacrolimus Dose

Efficacy and Safety of the Dipeptidyl Peptidase-4 Inhibitor Alogliptin in Patients With Type 2 Diabetes and Inadequate Glycemic Control

Efficacy and Safety of the Dipeptidyl Peptidase-4 Inhibitor Alogliptin in Patients With Type 2 Diabetes and Inadequate Glycemic Control : A randomized, double-blind, placebo-controlled study

Comparative Tacrolimus Pharmacokinetics: Normal versus Mildly Hepatically Impaired Subjects

Initial Combination Therapy With Alogliptin and Pioglitazone in Drug-Naïve Patients With Type 2 Diabetes

Efficacy and safety of the dipeptidyl peptidase-4 inhibitor alogliptin added to pioglitazone in patients with type 2 diabetes: a randomized, double-blind, placebo-controlled study

Pharmacokinetics of tacrolimus in liver transplant patients

Coadministration of Tacrolimus and Mycophenolate Mofetil in Stable Kidney Transplant Patients: Pharmacokinetics and Tolerability

Bioequivalence of 1 and 5 mg Tacrolimus Capsules Using a Replicate Study Design

Dose linearity after oral administration of tacrolimus 1-mg capsules at doses of 3, 7, and 10 mg

Tacrolimus oral bioavailability doubles with coadministration of ketoconazole

Pharmacokinetic, Pharmacodynamic, and olerability Profiles of the Dipeptidyl Peptidase-4 Inhibitor Alogliptin : A Randomized, Double-Blind, Placebo-Controlled, Multiple-Dose Study in Adult Patients with Type 2 Diabetes

Efficacy and safety of tacrolimus in patients with rheumatoid arthritis: A double‐blind trial

Tacrolimus in rheumatoid arthritis patients receiving concomitant methotrexate: A six-month, open-label study

Effect of Low- and High-Fat Meals on Tacrolimus Absorption following 5 mg Single Oral Doses to Healthy Human Subjects

Cytomegalovirus infection and posttransplant lymphoproliferative disease in renal transplant recipients: results of the U.S. multicenter FK506 Kidney Transplant Study Group

Bioequivalence of 1 and 5 mg Tacrolimus Capsules Using a Replicate Study Design

Plasma concentrations and disposition of clonidine following a constant 14-day epidural infusion in cancer patients

Coadministration of Tacrolimus and Mycophenolate Mofetil in Stable Kidney Transplant Patients: Pharmacokinetics and Tolerability

BROMOCRIPTINE LOWERS INTRAOCULAR PRESSURE WITHOUT AFFECTING BLOOD PRESSURE

Suchergebnisse filtern